Vaccine Invest Information

Companies
Valneva Seeks to Extend Use of Chikungunya Vaccine with Label Extension Submissions Sep 19, 2024
Pharmaceuticals
Valneva Seeks to Extend IXCHIQ® Usage Through EMA and Health Canada Applications Sep 18, 2024
Companies
Bharat Biotech Introduces Groundbreaking Oral Cholera Vaccine as Global Demand Soars Aug 28, 2024
Companies
Valneva's Innovative IXCHIQ® Becomes the First Chikungunya Vaccine Authorized in Europe Jul 1, 2024
Stocks
U.S. Health Authorities Advocate for RSV Vaccinations for Seniors, Impacting Pfizer's PFE Stake Jun 27, 2024
Companies
Valneva Showcases Innovative Chikungunya Vaccine at World Vaccine Congress Mar 21, 2024
Government
ICMR Study Finds No Link Between Covid Vaccines and Heart Attacks Mar 3, 2024
Healthcare
Decline in Cervical Cancer Mortality Rates as India Prepares to Implement HPV Vaccine Program Jan 15, 2024
Stocks
Valneva SE's Single-Dose Vaccine Proves Long-Lasting Immunity in Trial Dec 8, 2023
Pharmaceuticals
FDA Approves Ixchiq: First Vaccine for Chikungunya Virus by Valneva Nov 10, 2023
Stocks
Valneva SE's VALN Chikungunya Vaccine Receives FDA Approval, Company's Stock Rises Nov 10, 2023